Renaissance Wien Hotel
Linke Wienzeile/Ullmannstrasse 71, 1150 Vienna, Austria
This premier B2B event provides the appropriate platform to engage and discuss ideas with your fellow peers while facilitating a professional atmosphere and environment for good company representation and development.
The Summit will shed light on current challenges, best practices, and the inside view of the future of Microbiome in relation to precision medicine.
We will discuss key findings, critical insights, as well as recommendations for driving efficient strategies within the Microbiome landscape.
It is an honour and privilege to invite you to participate in this Summit. We look forward to welcoming you in Vienna this upcoming September!
Key Practical Learning Points of the Summit:
Who Should Attend:
Chief Executives, Directors, Vice Presidents, Department Heads, Leaders and Managers specialising in:
Dr. Outi Vaarala, SE VP, Head of Translational Biology Respiratory, Inflammation & Autoimmunity iMed (Innovative Medicines) & Early Development AstraZeneca
Dr. Oliver Chao, FR Head, Emerging Biomedical Sciences Strategy & Innovation Sanofi
Dr. Barbara Joyce-Shaikh, US Project Leader, Discovery Research Merck Research Laboratories
Dr. Dan Meyers, US Head of Product Development Janssen Human Microbiome Institute (JHMI
Dr. Jesús Zurdo, UK Sr Director Strategic Innovation Future Technologies Lonza Biologics plc
Dr. Marie A. Lindner, US Global Program Head, Strategic Partnerships Team Novartis
Dr. Henrik Bjørn Nielsen, DK Chief Scientific Officer Clinical-Microbiomics A/S
Pierre Belichard, FR CEO Enterome
Dr. Nicholas Monsul, US CEO & Co-Founder Quorum Innovations, LLC
Dr. Larry Weiss, US Chief Medical Officer AOBiome
Dr. Adam Baker, DK Head of Discovery, Microbiome and Human Health Chr. Hansen A/S
Dr. Olga Sakwinska, CH Research Scientist, Host Microbe Interaction Group Institute of Nutritional Science Nestec Ltd Nestlé Research Center
Dr. David Kyle, US CEO Evolve Biosystems Inc
Dr. Sheri Simmons, US Senior Scientist, Microbiome Sciences Seres Therapeutics
Dr. Benjamin Lelouvier, FR Chief Science Officer Vaiomer
Dr. Carlos Merino, CA Director Research & Innovation DNA Genotek Inc
Prof Dr. Wouter J de Jonge, NL Department of Gastroenterology Academic Medical Center (AMC) | Tytgat Institutefor GI and Liver Disease
Mike Romanos, UK CEO Microbiotica Biodata Innovation Centre Wellcome Genome Campus
Dr. Alexander Loy, AT Managing Director & Associate Professor Austrian Microbiome Initiative (AMICI) & Department of Microbiology and Ecosystem Science (DOME) Division of Microbial Ecology University of Vienna
To request an agenda for this Summit, please complete the details below. We will send an agenda to you via email.
To buy a documentation package for this Summit, please complete the details below. Upon receiving this form we will send an invoice for the documentation package. The cost for the documentation package is €500. Upon successfully receiving payment, we will send you the documentation package.